Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 279

1.

Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.

Jaglowski JR, Zagon IS, Stack BC Jr, Verderame MF, Leure-duPree AE, Manning JD, McLaughlin PJ.

Cancer Chemother Pharmacol. 2005 Jul;56(1):97-104. Epub 2005 Mar 25.

PMID:
15791460
[PubMed - indexed for MEDLINE]
2.

Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor.

McLaughlin PJ, Jaglowski JR, Verderame MF, Stack BC, Leure-Dupree AE, Zagon IS.

Int J Oncol. 2005 Mar;26(3):809-16.

PMID:
15703840
[PubMed - indexed for MEDLINE]
3.

Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration.

McLaughlin PJ, Stack BC Jr, Braine KM, Ruda JD, Zagon IS.

Int J Oncol. 2004 Jan;24(1):227-32.

PMID:
14654962
[PubMed - indexed for MEDLINE]
4.

Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.

McLaughlin PJ, Zagon IS.

Int J Oncol. 2006 Jun;28(6):1577-83.

PMID:
16685459
[PubMed - indexed for MEDLINE]
5.

Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice.

McLaughlin PJ, Levin RJ, Zagon IS.

Cancer Lett. 2003 Sep 25;199(2):209-17.

PMID:
12969794
[PubMed - indexed for MEDLINE]
6.

Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.

Zagon IS, Jaglowski JR, Verderame MF, Smith JP, Leure-Dupree AE, McLaughlin PJ.

Cancer Chemother Pharmacol. 2005 Nov;56(5):510-20. Epub 2005 Jun 10.

PMID:
15947928
[PubMed - indexed for MEDLINE]
7.

Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.

McLaughlin PJ, Verderame MF, Hankins JL, Zagon IS.

Int J Mol Med. 2007 Mar;19(3):421-8.

PMID:
17273790
[PubMed - indexed for MEDLINE]
8.

Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.

Zagon IS, McLaughlin PJ.

Int J Oncol. 2006 Aug;29(2):489-94.

PMID:
16820893
[PubMed - indexed for MEDLINE]
9.

Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.

McLaughlin PJ, Stucki JK, Zagon IS.

Head Neck. 2012 Apr;34(4):513-9. doi: 10.1002/hed.21759. Epub 2011 May 16.

PMID:
21584896
[PubMed - indexed for MEDLINE]
10.

Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor.

McLaughlin PJ, Levin RJ, Zagon IS.

Int J Oncol. 1999 May;14(5):991-8.

PMID:
10200353
[PubMed - indexed for MEDLINE]
11.

Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.

McLaughlin PJ, Kreiner S, Morgan CR, Zagon IS.

Int J Oncol. 2008 Oct;33(4):751-7.

PMID:
18813788
[PubMed - indexed for MEDLINE]
12.

Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.

Zagon IS, McLaughlin PJ.

Int J Oncol. 2004 Jun;24(6):1443-8.

PMID:
15138586
[PubMed - indexed for MEDLINE]
13.

Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.

Levin RJ, Wu Y, McLaughlin PJ, Zagon IS.

Laryngoscope. 1997 Mar;107(3):335-9.

PMID:
9121309
[PubMed - indexed for MEDLINE]
14.

The opioid growth factor receptor in human head and neck squamous cell carcinoma.

McLaughlin PJ, Levin RJ, Zagon IS.

Int J Mol Med. 2000 Feb;5(2):191-6.

PMID:
10639600
[PubMed - indexed for MEDLINE]
15.

Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck.

McLaughlin PJ, Stack BC Jr, Levin RJ, Fedok F, Zagon IS.

Cancer. 2003 Apr 1;97(7):1701-10.

PMID:
12655527
[PubMed - indexed for MEDLINE]
Free Article
16.

The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer.

Cheng F, Zagon IS, Verderame MF, McLaughlin PJ.

Cancer Res. 2007 Nov 1;67(21):10511-8.

PMID:
17974995
[PubMed - indexed for MEDLINE]
Free Article
17.

Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.

Zagon IS, Hytrek SD, Smith JP, McLaughlin PJ.

Cancer Lett. 1997 Jan 30;112(2):167-75.

PMID:
9066724
[PubMed - indexed for MEDLINE]
18.

2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.

Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Van Waes C.

Clin Cancer Res. 2004 Dec 15;10(24):8665-73.

PMID:
15623651
[PubMed - indexed for MEDLINE]
Free Article
19.

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.

McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D.

BMC Cancer. 2009 Oct 18;9:369. doi: 10.1186/1471-2407-9-369.

PMID:
19835629
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.

Zagon IS, Hytrek SD, Lang CM, Smith JP, McGarrity TJ, Wu Y, McLaughlin PJ.

Am J Physiol. 1996 Sep;271(3 Pt 2):R780-6.

PMID:
8853403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk